Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 4/20 | 0.48 |
| ▸ | THRA | P10827 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2835881 | 0.88 | MGLL (0.51) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL11711713 | 0.87 | NAAA (0.56) | FAAHTHRBTHRAMAPTDGKA | |
| SCHEMBL4979398 | 0.87 | NAAA (0.56) | FAAHTHRBTHRAMAPTDGKA | |
| Bromide SCHEMBL4608307 | 0.86 | THRB (0.58) | THRBTHRAALDH1A1MAPTDGKA | |
| SCHEMBL18300082 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL15847974 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL15848183 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL15848199 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL15847993 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 | |
| SCHEMBL15848185 | 0.85 | EPHX2 (0.50) | FAAHMGLLTHRBTHRAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024145281-A1 | BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-07-04 | — | — | WO | disclosed |